Recombinant multi-species LTBP2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine LTBP2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene belongs to the family of latent transforming growth factor (TGF)-beta binding proteins (LTBP), which are extracellular matrix proteins with multi-domain structure. This protein is the largest member of the LTBP family possessing unique regions and with most similarity to the fibrillins. It has thus been suggested that it may have multiple functions: as a member of the TGF-beta latent complex, as a structural component of microfibrils, and a role in cell adhesion. [provided by RefSeq, Jul 2008]
The Alternative Names of target: LTBP2,Latent-transforming growth factor beta-binding protein 2,LTBP-2,WMS3,GLC3D,LTBP3,MSPKA,MSTP031,C14orf141
Go
to LTBP2 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-SE0621-Ab-1/ GM-Tg-hg-SE0621-Ab-2 | Human LTBP2 protein | Human |
GM-Tg-rg-SE0621-Ab-1/ GM-Tg-rg-SE0621-Ab-2 | Rat LTBP2 protein | Rat |
GM-Tg-mg-SE0621-Ab-1/ GM-Tg-mg-SE0621-Ab-2 | Mouse LTBP2 protein | Mouse |
GM-Tg-cynog-SE0621-Ab-1/ GM-Tg-cynog-SE0621-Ab-2 | Cynomolgus/Rhesus macaque LTBP2 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-SE0621-Ab-1/ GM-Tg-felg-SE0621-Ab-2 | Feline LTBP2 protein | Feline |
GM-Tg-cang-SE0621-Ab-1/ GM-Tg-cang-SE0621-Ab-2 | Canine LTBP2 protein | Canine |
GM-Tg-bovg-SE0621-Ab-1/ GM-Tg-bovg-SE0621-Ab-2 | Bovine LTBP2 protein | Bovine |
GM-Tg-equg-SE0621-Ab-1/ GM-Tg-equg-SE0621-Ab-2 | Equine LTBP2 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. |
GM-Tg-hg-SE0621-Ab-1/ GM-Tg-hg-SE0621-Ab-2;
GM-Tg-rg-SE0621-Ab-1/ GM-Tg-rg-SE0621-Ab-2;
GM-Tg-mg-SE0621-Ab-1/ GM-Tg-mg-SE0621-Ab-2; GM-Tg-cynog-SE0621-Ab-1/ GM-Tg-cynog-SE0621-Ab-2; GM-Tg-felg-SE0621-Ab-1/ GM-Tg-felg-SE0621-Ab-2; GM-Tg-cang-SE0621-Ab-1/ GM-Tg-cang-SE0621-Ab-2; GM-Tg-bovg-SE0621-Ab-1/ GM-Tg-bovg-SE0621-Ab-2; GM-Tg-equg-SE0621-Ab-1/ GM-Tg-equg-SE0621-Ab-2 |
Products Name | LTBP2 protein |
Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
Target Name | LTBP2 |
Protein Sub-location | Secreted Protein/Potential Cytokines |
Isotypes | Recombinant protein |
Expression platform | Mammalian cell |
Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
Tag | His |
Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine LTBP2 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab
GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.